Economic Evaluation of First-Line Adjuvant Chemotherapies for Resectable Gastric Cancer Patients in China

BACKGROUND: First-line postoperative adjuvant chemotherapies with S-1 and capecitabine and oxaliplatin (XELOX) were first recommended for resectable gastric cancer patients in the 2010 and 2011 Chinese NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer; however, their economic impact in C...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Chongqing, Peng, Liubao, Zeng, Xiaohui, Li, Jianhe, Wan, Xiaomin, Chen, Gannong, Yi, Lidan, Luo, Xia, Zhao, Ziying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858361/
https://www.ncbi.nlm.nih.gov/pubmed/24340099
http://dx.doi.org/10.1371/journal.pone.0083396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858361/
https://www.ncbi.nlm.nih.gov/pubmed/24340099
http://dx.doi.org/10.1371/journal.pone.0083396

Ejemplares similares